Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pepper-Based patch tested against Kids' chronic nerve pain

NCT ID NCT05299294

Symptom relief Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study follows children aged 0 to 18 with chronic localized neuropathic pain who receive an 8% capsaicin patch as part of their routine care. Researchers will track whether the patch reduces pain and lessens the need for other pain treatments over six months. The goal is to see if this skin patch, derived from chili peppers, offers a safe and effective option for managing nerve pain in young patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an 8% capsaicin patch applied to the skin
What this could lead to
If successful, this could provide a non-drug option for managing chronic nerve pain in children, potentially reducing the need for other pain medications.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. Capsaicin can cause burning or stinging at the application site, and its effectiveness in children is not yet well established.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2022

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients aged less than 18-y with chronic localized neuropathic pain and capsaicin 8% patch indication validated in a pediatric chronic pain center. patient with intellectual development disabilities are accepted

Ages

Up to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * chronic localized neuropathic pain * capsaicin 8% patch treatment indication validated in a pediatric chronic pain center * agreement for participation by child and parents Exclusion Criteria: * already treated with capsaicin 8% patch in the same body area * already treated in the same study in an other investigation center * non willing to participate or parents not willing participation to the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain Neuropathic pain

Contacts and locations

Locations

  • CHR Bourg en Bresse

    Bourg-en-Bresse, France, 01000, France

  • CHRU Strasbourg

    Strasbourg, France, 67098, France

  • CHU Angers

    Angers, France, 49933, France

  • CHU Bordeaux

    Bordeaux, France, 33076, France

  • CHU Caen

    Caen, France, 14000, France

  • CHU Lille

    Lille, France, 59037, France

  • CHU Limoges

    Limoges, France, 87042, France

  • CHU Lyon

    Lyon, France

  • CHU Marseille

    Marseille, France, 13005, France

  • CHU Montpellier

    Montpellier, France, 34090, France

  • CHU Nancy

    Nancy, France, 54511, France

  • CHU Nantes

    Nantes, France, 44093, France

  • CHU Robert Debré

    Paris, France, 75019, France

  • CHU Rouen

    Rouen, France, 76031, France

  • CHU Toulouse

    Toulouse, France, 31059, France

  • CHU Tours

    Tours, France, 37044, France

  • CHU Trousseau

    Paris, France, 75571, France

  • CHU d'Amiens

    Amiens, 80054, France

  • CHU de Brest

    Brest, France, 29609, France

  • Institut Gustave Roussy

    Villejuif, France, 94805, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.